Table 3. Antimalarial drug administration if children went to referral health facility (RHF) at any stage of the treatment-seeking pathway, went to at least one other provider which was not a referral health facility (non-RHF provider), or did not go to any other provider after seeing the first provider.
| Children completing referral to RHF | Children seeking treatment from non-RHF providers§ | No second provider | Total | |||||
|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | |
| All | 1192 | 100 | 927 | 100 | 92 | 100 | 2211 | 100 |
| Case management* | ||||||||
| No antimalarial treatment | 62 | 5.2 | 43 | 4.6 | 7 | 7.6 | 112 | 5.1 |
| RAS only | 64 | 5.4 | 46 | 5.0 | 38 | 41.3 | 148 | 6.7 |
| Injection only | 23 | 1.9 | 28 | 3.0 | 0 | 0.0 | 51 | 2.3 |
| ACT only | 180 | 15.1 | 85 | 9.2 | 15 | 16.3 | 280 | 12.7 |
| RAS + injection | 64 | 5.4 | 118 | 12.7 | 0 | 0.0 | 182 | 8.2 |
| RAS + ACT | 212 | 17.8 | 129 | 13.9 | 32 | 34.8 | 373 | 16.9 |
| Injection + ACT | 104 | 8.7 | 104 | 11.2 | 0 | 0.0 | 208 | 9.4 |
| RAS + injection + ACT | 483 | 40.5 | 374 | 40.3 | 0 | 0.0 | 857 | 38.8 |
| Received ACT | 979 | 82.1 | 692 | 74.6 | 47 | 51.1 | 1718 | 77.7 |
| Dead at follow-up | 9 | 0.8 | 1 | 0.1 | 4 | 4.3 | 14 | 0.6 |
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |||
| Received ACT | Ref. | 0.64 | 0.51–0.79 | 0.21 | 0.14–0.34 | |||
| Dead at follow-up | Ref. | 0.14 | 0.02–1.12 | 5.97 | 1.80–19.78 | |||
* By any provider along the treatment-seeking pathway
§ CHWs, PHCs, private clinics, or drug shops
ACT = artemisinin-based combination therapy, CHW = community health worker, PHC = primary health centre, RAS = rectal artesunate, RHF = referral health facility